Financhill
Back

Halozyme Therapeutics Stock Predictions

Halozyme Therapeutics Stock Forecast

  • Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 29.7% based on the past 20 years of stock performance.
  • Halozyme Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Halozyme Therapeutics Stock Undervalued?
    The current Halozyme Therapeutics [HALO] share price is $45.76. The Score for HALO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Halozyme Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 29.7% based on the past 20 years of stock performance.

Halozyme Therapeutics Stock Rating

Sell
44
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics overpriced?

  • Halozyme Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Halozyme Therapeutics Stock Price History

Is HALO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com

52-Week Data

52-Week High:
65.53
52-Week Low:
33.15

Prediction Charts

Market Cap:
5.82B
Price in USD:
45.76
Volume:
1.85M
Beta:
1.48

Technical Analysis

SMA50:
55.29
SMA100:
56.04
SMA200:
49.09
52-Wk Change:
14.37%

Stock Predictions

  • Is Halozyme Therapeutics stock public?
    Yes, Halozyme Therapeutics is a publicly traded company.
  • What is the Halozyme Therapeutics stock quote today?
    The Halozyme Therapeutics stock price is 45.76 USD today.
  • How to buy Halozyme Therapeutics stock online?
    You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 55.66 57.15 57.62 52.56
Nov-4 56.82 58.46 59.39 56.82
Nov-5 58.00 58.72 58.74 57.09
Nov-6 60.55 60.65 61.49 58.01
Nov-7 60.66 59.65 60.95 58.76
Nov-8 59.65 61.01 61.19 59.14
Nov-11 61.13 61.09 62.13 60.55
Nov-12 61.08 59.64 62.02 59.24
Nov-13 59.79 58.61 60.37 58.46
Nov-14 58.25 53.96 59.80 53.84
Nov-15 48.81 45.65 49.64 45.63
Nov-18 45.66 42.57 45.71 42.01
Nov-19 43.81 44.81 45.30 42.65
Nov-20 44.57 45.76 46.20 44.10

Halozyme Therapeutics Earnings

Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Halozyme Therapeutics Forecast Revenue Growth

Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.